易瑞生物实控人方13个月减持574.26万股 套现6274.8万

Core Viewpoint - The announcement from EasyRegen Bio indicates a significant reduction in shareholding by its major shareholders, which may impact the company's ownership structure but will not affect its governance or ongoing operations [1][3]. Shareholding Changes - EasyRegen Bio's major shareholders, including EasyRegen (Hainan) Venture Capital Co., Ltd., Zhu Hai, and their affiliates, have collectively reduced their shareholding from 246,901,504 shares (61.5922%) to 241,158,904 shares (59.9987%) [1][3]. - The reduction in shareholding was achieved through various transactions, including block trades and centralized bidding, with a total of 5,742,600 shares sold between July 2024 and August 2025 [2][3]. Transaction Details - Specific transactions include: - EasyKaiRui reduced its holdings by 967,700 shares from July 9 to July 10, 2024, and from April 30 to June 4, 2025 [1]. - EasyDaRui sold 754,900 shares during the same periods [1]. - Zhu Hai sold a total of 4,020,000 shares from July 28 to August 11, 2025 [2]. - The total cash generated from these reductions is approximately 62.7481 million yuan [3]. Financial Impact - The average selling prices for the shares sold by EasyDaRui and EasyKaiRui were 6.92 yuan/share and 7.29 yuan/share, respectively, indicating a strategic exit at varying price points [2]. - Zhu Hai's total cash from share sales is estimated at around 48.98 million yuan based on the weighted average price of 12.183 yuan/share during the selling period [2].